TUMOR-NECROSIS-FACTOR-ALPHA ALTERS THE METABOLISM OF ENDOTHELIAL-CELL PROTEOGLYCANS

被引:3
|
作者
MATIC, M [1 ]
LEVEUGLE, B [1 ]
FILLIT, HM [1 ]
机构
[1] MT SINAI MED CTR,DEPT GERIATR & ADULT DEV,NEW YORK,NY 10029
关键词
PROTEOGLYCANS; GLYCOSAMINOGLYCANS; HEPARAN SULFATE; EXTRACELLULAR MATRIX; TUMOR NECROSIS FACTOR; CYTOKINES; VASCULAR DISEASE; ENDOTHELIAL CELLS; CELL CYCLE;
D O I
10.3109/08916939409009529
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytokines play an important role in modulating cellular function. The effect of tumor necrosis factor alpha (TNF-alpha) on the metabolism of proteoglycans (PGs) was studied in mouse aortic endothelial cells (MAE). Confluent and exponentially growing cells were labeled with [S-35] sulfate and [H-3] glycine, and PGs isolated from the secreted, the pericellular, and intracellular pools. TNF-alpha influenced the metabolism of MAE PGs. This effect of TNF-alpha was dependent on the growth state of the cells. Nondividing MAE secrete PGs that have higher net negative charge than PGs from exponentially growing cells. TNF-alpha treatment further increased the net negative charge of PGs secreted from nondividing cells. Treatment of MAE with TNF-alpha caused a substantial decrease in the sulfation of PGs isolated from pericellular pool of nondividing cells, while it had the opposite effect on pericellular PGs isolated from dividing cells. Our results indicate that changes in PGs metabolism induced by TNF-alpha may contribute to the disturbance of vascular endothelial homeostasis associated with vascular injury in a variety of disease states.
引用
收藏
页码:275 / 284
页数:10
相关论文
共 50 条
  • [1] ENDOTHELIAL-CELL ACTIVATION BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND THE DEVELOPMENT OF PREECLAMPSIA
    MEEKINS, JW
    MCLAUGHLIN, PJ
    WEST, DC
    MCFADYEN, IR
    JOHNSON, PM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 98 (01): : 110 - 114
  • [2] TUMOR-NECROSIS-FACTOR-ALPHA INHIBITS ENDOTHELIAL-CELL PROLIFERATION INVITRO, BUT IS ANGIOGENIC INVIVO
    FRATERSCHRODER, M
    RISAU, W
    HALLMANN, R
    BOHLEN, P
    EXPERIENTIA, 1987, 43 (06): : 637 - 637
  • [3] RESPONSES OF VASCULAR ENDOTHELIAL OXIDANT METABOLISM TO LIPOPOLYSACCHARIDE AND TUMOR-NECROSIS-FACTOR-ALPHA
    ROYALL, JA
    GWIN, PD
    PARKS, DA
    FREEMAN, BA
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 294 (02) : 686 - 694
  • [4] TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-ALPHA ENHANCE LIPOPOLYSACCHARIDE-MEDIATED BOVINE ENDOTHELIAL-CELL INJURY
    SHARMA, SA
    OLCHOWY, TWJ
    YANG, ZG
    BREIDER, MA
    JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 51 (06) : 579 - 585
  • [5] ENDOTHELIAL-CELL PRODUCTION OF TUMOR NECROSIS FACTOR
    CASEY, LC
    MODI, H
    SIMPSON, S
    FASEB JOURNAL, 1988, 2 (06): : A1599 - A1599
  • [6] MODULATION OF ENDOTHELIAL-CELL TRANSFORMING GROWTH-FACTOR-BETA PRODUCTION BY INTERLEUKIN-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA
    PHAN, SH
    MCGARRY, BM
    KUNKEL, SL
    RYAN, US
    FASEB JOURNAL, 1991, 5 (04): : A517 - A517
  • [7] TUMOR-NECROSIS-FACTOR-ALPHA ALTERS BOVINE LUTEAL CELL SYNTHETIC CAPACITY AND VIABILITY
    BENYO, DF
    PATE, JL
    ENDOCRINOLOGY, 1992, 130 (02) : 854 - 860
  • [8] TUMOR-NECROSIS-FACTOR-ALPHA
    ROCK, CS
    LOWRY, SF
    JOURNAL OF SURGICAL RESEARCH, 1991, 51 (05) : 434 - 445
  • [9] DIFFERENTIAL-EFFECTS OF SMALL TUMOR-NECROSIS-FACTOR-ALPHA PEPTIDES ON TUMOR-CELL CYTOTOXICITY, NEUTROPHIL ACTIVATION AND ENDOTHELIAL-CELL PROCOAGULANT ACTIVITY
    RATHJEN, DA
    FERRANTE, A
    ASTON, R
    IMMUNOLOGY, 1993, 80 (02) : 293 - 299
  • [10] TUMOR-NECROSIS-FACTOR-ALPHA ALTERS MATERNAL AND EMBRYONIC ZINC-METABOLISM AND IS DEVELOPMENTALLY TOXIC IN MICE
    TAUBENECK, MW
    DASTON, GP
    ROGERS, JM
    GERSHWIN, ME
    ANSARI, A
    KEEN, CL
    JOURNAL OF NUTRITION, 1995, 125 (04): : 908 - 919